229 related articles for article (PubMed ID: 35505944)
41. Formulations of Topical Steroids in Eosinophilic Esophagitis-Current Treatment and Emerging Possibilities.
Główczewski A; Krogulska A
J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268544
[TBL] [Abstract][Full Text] [Related]
42. Prospective, comparative effectiveness trial of cow's milk elimination and swallowed fluticasone for pediatric eosinophilic esophagitis.
Kruszewski PG; Russo JM; Franciosi JP; Varni JW; Platts-Mills TA; Erwin EA
Dis Esophagus; 2016 May; 29(4):377-84. PubMed ID: 25721813
[TBL] [Abstract][Full Text] [Related]
43. Management of Eosinophilic Esophagitis: Dietary and Nondietary Approaches.
Chen JW
Nutr Clin Pract; 2020 Oct; 35(5):835-847. PubMed ID: 32822071
[TBL] [Abstract][Full Text] [Related]
44. Emerging drugs for eosinophilic esophagitis.
Kern E; Hirano I
Expert Opin Emerg Drugs; 2013 Sep; 18(3):353-64. PubMed ID: 23937314
[TBL] [Abstract][Full Text] [Related]
45. Eosinophilic esophagitis in children.
Trivedy P; Teitelbaum JE
Paediatr Drugs; 2015 Jun; 17(3):227-37. PubMed ID: 25792526
[TBL] [Abstract][Full Text] [Related]
46. Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use.
Spergel BL; Ruffner MA; Godwin BC; Liacouras CA; Cianferoni A; Gober L; Hill DA; Brown-Whitehorn TF; Chaiboonma K; Aceves SA; Muir AM; Spergel JM
Ann Allergy Asthma Immunol; 2022 May; 128(5):589-593. PubMed ID: 35085819
[TBL] [Abstract][Full Text] [Related]
47. Pediatric Eosinophilic Esophagitis Endotypes: Are We Closer to Predicting Treatment Response?
Ferguson AE; Mukkada VA; Fulkerson PC
Clin Rev Allergy Immunol; 2018 Aug; 55(1):43-55. PubMed ID: 29270819
[TBL] [Abstract][Full Text] [Related]
48. Steroid Eluting Esophageal-Targeted Drug Delivery Devices for Treatment of Eosinophilic Esophagitis.
Prasher A; Shrivastava R; Dahl D; Sharma-Huynh P; Maturavongsadit P; Pridgen T; Schorzman A; Zamboni W; Ban J; Blikslager A; Dellon ES; Benhabbour SR
Polymers (Basel); 2021 Feb; 13(4):. PubMed ID: 33668571
[TBL] [Abstract][Full Text] [Related]
49. Histological Outcomes of Pharmacological Interventions in Eosinophilic Esophagitis for Adults and Children: A Network Meta-analysis of Randomized Controlled Trials.
Aziz M; Haghbin H; Gangwani MK; Fatima R; Sohail AH; Ali H; Alyousif ZA; Dahiya DS; Lee-Smith W; Beran A; Kamal F; Nawras A
J Clin Gastroenterol; 2024 May; ():. PubMed ID: 38701235
[TBL] [Abstract][Full Text] [Related]
50. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis.
Andreae DA; Hanna MG; Magid MS; Malerba S; Andreae MH; Bagiella E; Chehade M
Am J Gastroenterol; 2016 Aug; 111(8):1187-97. PubMed ID: 27325220
[TBL] [Abstract][Full Text] [Related]
51. Food allergy and eosinophilic esophagitis: what do we do?
Chehade M; Aceves SS; Furuta GT; Fleischer DM
J Allergy Clin Immunol Pract; 2015; 3(1):25-32. PubMed ID: 25577614
[TBL] [Abstract][Full Text] [Related]
52. Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis.
Albert D; Heifert TA; Min SB; Maydonovitch CL; Baker TP; Chen YJ; Moawad FJ
Dig Dis Sci; 2016 Jul; 61(7):1996-2001. PubMed ID: 27093866
[TBL] [Abstract][Full Text] [Related]
53. Dupilumab Leads to Clinical Improvements including the Acquisition of Tolerance to Causative Foods in Non-Eosinophilic Esophagitis Eosinophilic Gastrointestinal Disorders.
Arakawa N; Yagi H; Shimizu M; Shigeta D; Shimizu A; Nomura S; Takizawa T; Yamada Y
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671497
[TBL] [Abstract][Full Text] [Related]
54. Current Diagnostic and Treatment Strategies for Eosinophilic Esophagitis.
Lipowska AM; Kavitt RT
Gastroenterol Hepatol (N Y); 2017 Sep; 13(9):527-535. PubMed ID: 29038643
[TBL] [Abstract][Full Text] [Related]
55. Steroids in pediatric eosinophilic esophagitis.
Contreras EM; Gupta SK
Gastroenterol Clin North Am; 2014 Jun; 43(2):345-56. PubMed ID: 24813520
[TBL] [Abstract][Full Text] [Related]
56. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis.
Peterson KA; Thomas KL; Hilden K; Emerson LL; Wills JC; Fang JC
Dig Dis Sci; 2010 May; 55(5):1313-9. PubMed ID: 19533356
[TBL] [Abstract][Full Text] [Related]
57. Emerging therapeutic strategies for eosinophilic esophagitis.
Lucendo AJ; Molina-Infante J
Curr Treat Options Gastroenterol; 2014 Mar; 12(1):1-17. PubMed ID: 24370990
[TBL] [Abstract][Full Text] [Related]
58. Eosinophilic esophagitis: current perspectives from diagnosis to management.
Moawad FJ; Cheng E; Schoepfer A; Al-Haddad S; Bellizzi AM; Dawson H; El-Zimaity H; Guindi M; Penagini R; Safrooneva E; Chehade M
Ann N Y Acad Sci; 2016 Sep; 1380(1):204-217. PubMed ID: 27467185
[TBL] [Abstract][Full Text] [Related]
59. Eosinophilic esophagitis: Pathophysiology, diagnosis, and management.
Vinit C; Dieme A; Courbage S; Dehaine C; Dufeu CM; Jacquemot S; Lajus M; Montigny L; Payen E; Yang DD; Dupont C
Arch Pediatr; 2019 Apr; 26(3):182-190. PubMed ID: 30827775
[TBL] [Abstract][Full Text] [Related]
60. Eosinophilic esophagitis in adults: an update on medical management.
Prieto R; Richter JE
Curr Gastroenterol Rep; 2013 Jun; 15(6):324. PubMed ID: 23703154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
